沙法兰 (Crocus sativus L.) 和其副产品:在内科医学中的健康影响
Giulia Marrone1, Silvia Urciuoli2, Manuela Di Lauro1
1Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Nutrients
|July 27, 2024
概括
番茄 (Crocus sativus L.) 和其副产品提供了显著的抗氧化和抗炎功效. 本次审查强调了它们在预防和治疗各种疾病方面的潜力,促进了可持续的生物循环经济.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 可持续经济 可持续经济
背景情况:
- (Crocus sativus L.) 是一种有价值的香料,主要在伊朗生产.
- 沙弗朗的污名在食品,制药和化品中使用.
- 沙夫兰的副产品富含生物活性化合物,具有健康益处.
研究的目的:
- 审查沙夫兰在内科医学中的治疗应用.
- 为了突出香在预防和治疗各种病理方面的作用.
- 为了促进沙夫兰副产品的利用,以实现可持续性.
主要方法:
- 科学论文的文献评论关于沙夫兰对健康的影响.
- 对沙拉的抗氧化和抗炎性质的分析.
- 在生物循环经济框架内探索沙夫兰副产品.
主要成果:
- 沙弗朗表现出显著的抗氧化和抗炎作用,降低了促炎细胞因子.
- 它在治疗退行性黄斑病,抑郁症,焦虑症,神经退行性疾病,代谢综合征,癌症和慢性病方面表现出潜力.
- 沙法兰促进葡萄糖代谢,有助于疾病管理.
结论:
- 沙法兰是一种有价值的天然化合物,用于疾病预防和治疗.
- 番茄的副产品是生物循环经济的可持续资源.
- 使用沙法兰副产品最大限度地提高了资源效率,并促进了环境可持续性.
相关概念视频
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
236
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
236
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Factors Influencing Drug Absorption: Disease States and Pharmacology
481
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
481
Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436


